Delivery Order SPE2DE21D7010-SPE2D626F09Q4
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and implants, has been awarded a $39,829.90 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense-focused federal agency. The contract, designated as RELINE-ONE, is structured as a fixed-price delivery order with economic price adjustment mechanisms and carries no set-aside designation, indicating open market competition. The place of performance is San Diego,...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $12,607.94 fixed-price delivery order (contract number 4570040417) by the Defense Logistics Agency Medical Supply Chain on November 13, 2025, for RELINE OPEN IMPLANTS to be delivered by December 5, 2025. The contract was awarded without set-aside designation through open market competition and includes an economic price adjustment mechanism to accommodate cost fluctuations....
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order on November 3, 2025, for RELINE MAS IMPLANTS with a ceiling value of $22,376.93 and an ultimate completion date of November 24, 2025. This fixed-price contract with economic price adjustment was issued without set-aside designation by the Defense Logistics Agency Medical Supply Chain, a component of the Department of Defense responsible for procuring medical...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products and services, was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on May 8, 2025. This fixed-price delivery order with economic price adjustment mechanism carries an ultimate completion date of May 9, 2025, and is not associated with any set-aside designation, indicating open market competition. The contract supports the federal healthcare system's...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products, was awarded a $10,525.48 delivery order (RELINE-C) by the Defense Logistics Agency Medical Supply Chain on May 30, 2025. The contract utilizes a fixed-price with economic price adjustment pricing structure and carries no set-aside designation, indicating competitive open-market procurement. Performance is scheduled to conclude by June 20, 2025, at the company's San Diego, California location. This...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $12,646.10 fixed-price delivery order (Contract #4570184048) on December 2, 2025, for RELINE OPEN IMPLANTS. This delivery order, issued without set-aside designation, is funded through the Defense Logistics Agency Medical Supply Chain and includes an economic price adjustment mechanism to address cost fluctuations. Performance is scheduled for completion by December 3,...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $9,642.60 on December 11, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as a firm fixed-price delivery order with economic price adjustment mechanisms, is scheduled for completion by January 2, 2026. This award was issued without set-aside restrictions, indicating competitive open market procurement. Nuvasive...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $4,682.23 on December 5, 2025, for RELINE MAS IMPLANTS through the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of December 30, 2025. No set-aside designation was used in this competitive procurement....
- Nuvasive, Inc., a San Diego-based medical device manufacturer, was awarded a $13,362.36 fixed-price delivery order (Contract No. 4570340917) on December 10, 2025, for the RELINE-C spinal implant system, with performance scheduled for completion by December 11, 2025, at the company's San Diego, California facility. The contract was funded through the Defense Logistics Agency Medical Supply Chain without set-aside designation, reflecting open competition among qualified medical device suppliers....
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products, was awarded a $46,066.90 fixed-price delivery order (Contract No. 4568371925, RELINE-ONE) by the Defense Logistics Agency (DLA) Medical Supply Chain on May 28, 2025. The delivery order, which utilizes an economic price adjustment mechanism, is scheduled for ultimate completion on May 29, 2025, and will be performed in San Diego, California. This award was made without a set-aside designation,...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F09Q4Delivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer, was awarded a delivery order valued at $31,501.86 on December 11, 2025, for the supply of RELINE-ONE spinal implant products. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of January 2, 2026. This award was issued by the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for procuring medical supplies and equipment for Department of Defense and Department of Veterans Affairs healthcare facilities. The contract was awarded on a competitive, open market basis with no set-aside designation, demonstrating Nuvasive's competitive standing among medical device suppliers serving federal healthcare agencies. Performance will be conducted at Nuvasive's facility in San Diego, California. This delivery order is issued under the broader framework of Nuvasive's substantial federal contract portfolio with the Defense Logistics Agency and represents the company's ongoing role as a critical supplier of advanced spinal surgical products and bone graft materials to military and veteran healthcare systems. Nuvasive operates as a subsidiary of Transplant Technology Inc. and benefits from its parent company's $8 million Blanket Purchase Agreement with the Defense Health Agency structured as an Indefinite Delivery/Indefinite Quantity contract vehicle effective through March 2027. This strategic BPA framework enables streamlined procurement and rapid ordering of Nuvasive's comprehensive portfolio of spinal fusion devices, implants, surgical instruments, and biologics across Department of Defense and Department of Veterans Affairs medical facilities nationwide, supporting the operational readiness and medical mission effectiveness of federal healthcare enterprises.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.5k | 12/10/25 |